Invivyd to Participate at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
05.02.2024 - WALTHAM, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) - Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that David Hering, Chief Executive Officer of ...
Source: wallstreet-online.de